Get the Stockscreener App
6.45
8.59%
0.51
After Hours:
6.57
0.12
+1.86%
Immatics N V stock is traded at $6.45, with a volume of 236.89K.
It is up +8.59% in the last 24 hours and up +19.00% over the past month.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$5.94
Open:
$6.34
24h Volume:
236.89K
Relative Volume:
0.40
Market Cap:
$784.00M
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-4.9627
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
+5.22%
1M Performance:
+19.00%
6M Performance:
+15.80%
1Y Performance:
-50.08%
1-Day Range:
$6.33
$6.50
1-Week Range:
$5.70
$6.50
52-Week Range:
$3.30
$13.09
Immatics N V Stock (IMTX) Company Profile
Compare IMTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
6.45 | 722.01M | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
What analysts say about Immatics N.V. stockExceptional return forecasts - Autocar Professional
What drives Immatics N.V. stock priceExplosive market performance - jammulinksnews.com
Immatics N.V. Equity Warrant Stock Analysis and ForecastUnprecedented growth rates - Autocar Professional
Long Term Trading Analysis for (IMTX) - news.stocktradersdaily.com
Immatics N.V. Stock Analysis and ForecastHigh-impact stock picks - Autocar Professional
Is Immatics N.V. a good long term investmentExplosive portfolio gains - jammulinksnews.com
Is Immatics N.V. Equity Warrant a good long term investmentSuperior stock growth - jammulinksnews.com
What analysts say about Immatics N.V. Equity Warrant stockDynamic profit opportunities - jammulinksnews.com
How Immatics N.V. stock performs during market volatilityFree Top-Rated Stock Analysis - Newser
Immatics N.V. (NASDAQ:IMTX) Receives $14.67 Average Target Price from Brokerages - Defense World
What drives Immatics N.V. Equity Warrant stock priceSuperior investment outcomes - jammulinksnews.com
Published on: 2025-07-19 07:11:45 - Jammu Links News
Immatics (NASDAQ:IMTX) Shares Up 2.9% – What’s Next? - Defense World
Why Immatics N.V. Equity Warrant stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser
Why Immatics N.V. stock attracts strong analyst attentionFree Best Stocks to Buy Today - Newser
What makes Immatics N.V. Equity Warrant stock price move sharplyVolume Spike Monitors - Newser
What makes Immatics N.V. stock price move sharplyFree Stock Market Forecasting Tools - Newser
How Immatics N.V. Equity Warrant stock performs during market volatilityFree Group Entry - Newser
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.91%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):